Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Health Care Reform: For Biopharmas There Is Much To Like

Apr 01 2010

Related Content

A Quick Metric for Measuring Pharma's Success in Healthcare Reform

Nov 01 2009

Big Pharma May Be Big Player in Follow-On Biologics Market

Apr 01 2008

On The Cusp Of Biosimilars: Reform Ushers In Next Generic Drug Era

Mar 29 2010

Merck's Head-long Leap into Follow-On Biologics

Dec 01 2008

FDA Hesitates on Biogenerics

Oct 01 2004

A Two Pharma Horse Race In Follow-On Biologics

Feb 01 2009

Biotech Backers Are Learning to Live with Exit-by-Earn-out

Mar 01 2010

Related Companies

Roche Holding AG

Abbott

Pfizer Inc.

Eli Lilly and Company

Merck & Co., Inc.

Merck & Co., Inc.

Insmed Incorporated

Pelican Technology Holdings, Inc.

FUJIFILM Holdings Corp.

Protalix BioTherapeutics, Inc.

Sanofi Genzyme

Novartis AG

Novartis AG

Teva Pharmaceutical Industries Ltd.

Allergan plc

Dr. Reddy's Laboratories Ltd.

Viatris Inc.

Hospira, Inc.

Lonza Group AG

National Institutes of Health

Gyre Therapeutics, Inc.

GlycoMimetics, Inc.

Additional Topics

Business Strategies Leadership Platform Technologies Regulation Reimbursement BioPharmaceutical

More from Business Strategy

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window